FASN and breast carcinoma: These findings confirm and extend earlier studies showing that the formation of a hyperactive heterodimer between HER2 and HER3 and the downstream activation of PI-3K/AKT and MAPK-ERK1/2 signaling cascades are essential traits for HRG-mediated elevation of FASN in breast cancer cells [29].